Synthetic Peptide
INCA1 Synthetic Peptide, PEP-0977, from Invitrogen.
Binds to CDK2-bound cyclins and inhibits the kinase activity of CDK2; binding to cyclins is critical for its function as CDK inhibitor (PubMed:21540187). Inhibits cell growth and cell proliferation and may play a role in cell cycle control. Required for ING5-mediated regulation of S-phase progression, enhancement of Fas-induced apoptosis and inhibition of cell growth. [UniProt]
| Marque | Invitrogen |
|---|---|
| Réf. B-LABO | BL-RE-175965 |
| Réf. fabricant | 15359230 |
| Gene ID (Entrez) | 388324 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | Q0VD86 |
| Nom usuel | Human INCA1 |
| Concentration | 200 μg/mL |
| Contenu et stockage | -20°C |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Symbole de gène(s) | INCA1 |
| Lyophilisé | No |
| Conservateur | 0.02% sodium azide |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Tampon de stockage | PBS |
